Archives: 2022-01-04

PIER MARIA FORNASARI
2022-01-04

Emergence in Southern France of a new SARS-CoV-2 variant named B.1.640.2 of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein and present in 67 hospitalised patients

A new coronavirus variant has been discovered in southern France, spreading in a small outbreak, according to a new study.The variant, tentatively identified B.1.640.2 according to a recent study backed by the French government that has yet to be peer-reviewed, is believed to be Cameroonian in origin and have so far spread to 67 patients in southern France.

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-03

A potential at-home COVID-19 test is just as good as laboratory PCR tests, according to preclinical data

Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest that tests with the new assay may be just as reliable as the laboratory-based molecular tests — called PCR tests — used by hospitals for clinical diagnostics.  “Having fast and

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-02

Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain types of blood cancers. Now, scientists at Memorial Sloan Kettering Cancer Center’s Sloan Kettering Institute (SKI) have developed new CAR T cells that can do something their

Read More

No Comments InCAR-T